WST – West Pharmaceutical Services, Inc.
WST — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.4
Margin Of Safety %
-9
Put/Call OI Ratio
0.75
EPS Next Q Diff
-0.1
EPS Last/This Y
1.67
EPS This/Next Y
1.02
Price
376.76
Target Price
413.07
Analyst Recom
1.3
Performance Q
5.77
Upside
-54.3%
Beta
1.15
Ticker: WST
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-09-08 | WST | 338.01 | 0.84 | 1.46 | 5007 |
| 2026-09-09 | WST | 337.09 | 0.85 | 0.06 | 5065 |
| 2026-09-10 | WST | 344.12 | 0.85 | 1.06 | 5072 |
| 2026-09-11 | WST | 346.22 | 0.85 | 0.06 | 5111 |
| 2026-09-14 | WST | 355.15 | 0.71 | 0.09 | 5737 |
| 2026-09-15 | WST | 365.01 | 0.64 | 0.26 | 6166 |
| 2026-09-16 | WST | 362.01 | 0.62 | 0.05 | 6285 |
| 2026-09-17 | WST | 366.37 | 0.61 | 0.05 | 6384 |
| 2026-09-18 | WST | 362.32 | 0.60 | 0.03 | 6396 |
| 2026-09-21 | WST | 361.73 | 0.87 | 0.12 | 4231 |
| 2026-09-22 | WST | 371.15 | 0.86 | 0.26 | 4263 |
| 2026-09-23 | WST | 375.97 | 0.84 | 0.26 | 4303 |
| 2026-09-24 | WST | 373.64 | 0.84 | 0.03 | 4332 |
| 2026-09-25 | WST | 370.42 | 0.76 | 0.20 | 4595 |
| 2026-09-28 | WST | 375.84 | 0.76 | 0.06 | 4600 |
| 2026-09-29 | WST | 376.66 | 0.73 | 0.87 | 4703 |
| 2026-09-30 | WST | 370.74 | 0.73 | 0.24 | 4732 |
| 2026-10-01 | WST | 364.96 | 0.75 | 0.22 | 4691 |
| 2026-10-02 | WST | 364.98 | 0.76 | 0.28 | 4775 |
| 2026-10-05 | WST | 376.65 | 0.75 | 0.06 | 4838 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-09-08 | WST | 338.11 | 11.7 | 131.3 | 8.96 |
| 2026-09-09 | WST | 338.10 | 11.7 | 137.2 | 8.96 |
| 2026-09-10 | WST | 344.44 | 11.7 | 154.6 | 8.96 |
| 2026-09-11 | WST | 346.06 | 11.7 | 140.3 | 8.96 |
| 2026-09-14 | WST | 355.15 | 11.7 | 157.5 | 8.96 |
| 2026-09-15 | WST | 364.84 | 11.9 | 158.7 | 8.96 |
| 2026-09-16 | WST | 364.84 | 11.9 | 158.7 | 8.96 |
| 2026-09-17 | WST | 366.45 | 11.9 | 146.2 | 8.96 |
| 2026-09-18 | WST | 362.23 | 11.9 | 125.9 | 8.96 |
| 2026-09-21 | WST | 361.84 | 11.9 | 134.8 | 8.96 |
| 2026-09-22 | WST | 371.52 | 11.9 | 158.5 | 8.96 |
| 2026-09-23 | WST | 375.91 | 11.9 | 146.8 | 8.96 |
| 2026-09-24 | WST | 373.54 | 11.9 | 130.7 | 8.96 |
| 2026-09-25 | WST | 370.42 | 11.9 | 128.8 | 8.96 |
| 2026-09-28 | WST | 375.66 | 11.9 | 147.7 | 8.96 |
| 2026-09-29 | WST | 376.74 | 11.9 | 138.3 | 8.96 |
| 2026-09-30 | WST | 370.68 | 11.9 | 122.6 | 8.96 |
| 2026-10-01 | WST | 364.97 | 11.9 | 122.8 | 8.96 |
| 2026-10-02 | WST | 364.98 | 11.9 | 122.6 | 8.96 |
| 2026-10-05 | WST | 376.76 | 11.9 | 149.4 | 8.96 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-09-08 | WST | -0.70 | -2.07 | 3.04 |
| 2026-09-09 | WST | -0.70 | -2.07 | 3.04 |
| 2026-09-10 | WST | -0.70 | -2.07 | 3.04 |
| 2026-09-11 | WST | -2.20 | -2.07 | 3.14 |
| 2026-09-14 | WST | -2.20 | -2.14 | 3.14 |
| 2026-09-15 | WST | -2.20 | -2.14 | 3.14 |
| 2026-09-16 | WST | -3.50 | -2.14 | 3.14 |
| 2026-09-17 | WST | -3.50 | -2.14 | 3.14 |
| 2026-09-18 | WST | -3.50 | -2.14 | 3.14 |
| 2026-09-21 | WST | -3.50 | -2.14 | 3.14 |
| 2026-09-23 | WST | -3.54 | -2.14 | 3.14 |
| 2026-09-24 | WST | -3.54 | -2.14 | 3.14 |
| 2026-09-25 | WST | -3.54 | -2.14 | 3.40 |
| 2026-09-28 | WST | -3.54 | -2.18 | 3.40 |
| 2026-09-29 | WST | -3.54 | -2.18 | 3.40 |
| 2026-09-30 | WST | -3.54 | -2.18 | 3.40 |
| 2026-10-01 | WST | -3.54 | -2.18 | 3.40 |
| 2026-10-02 | WST | -3.54 | -2.18 | 3.40 |
| 2026-10-05 | WST | -3.54 | -2.19 | 3.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.37
Avg. EPS Est. Current Quarter
2.19
Avg. EPS Est. Next Quarter
2.27
Insider Transactions
-3.54
Institutional Transactions
-2.19
Beta
1.15
Average Sales Estimate Current Quarter
825
Average Sales Estimate Next Quarter
826
Fair Value
344.06
Quality Score
96
Growth Score
86
Sentiment Score
32
Actual DrawDown %
20.7
Max Drawdown 5-Year %
-59.3
Target Price
413.07
P/E
48.15
Forward P/E
37.68
PEG
2.31
P/S
7.97
P/B
8.87
P/Free Cash Flow
60.66
EPS
7.82
Average EPS Est. Cur. Y
8.96
EPS Next Y. (Est.)
9.98
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
16.98
Relative Volume
1.07
Return on Equity vs Sector %
-7.2
Return on Equity vs Industry %
9.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
149.4
◆
WST
Healthcare
$376.61
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
62.8
Range 1M
87.3%
Sup Dist
3.7%
Momentum Growth
Ride accelerating trends
WATCH
EPS Yr
23.1%
EPS NY
11.4%
52W%
94%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-21.5% upside
Upside
-21.5%
Quality
96
MoS
-9%
WST — P/E HistoricalMedical Instruments & Supplies
West Pharmaceutical Services, ISector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 10800
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
WST
Latest News
—
Caricamento notizie per WST…
stock quote shares WST – West Pharmaceutical Services, Inc. Stock Price stock today
news today WST – West Pharmaceutical Services, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch WST – West Pharmaceutical Services, Inc. yahoo finance google finance
stock history WST – West Pharmaceutical Services, Inc. invest stock market
stock prices WST premarket after hours
ticker WST fair value insiders trading